Chemsex refers to the use of specific drugs, such as methamphetamine and GHB/GBL, before or during sex to sustain, enhance, disinhibit, or facilitate the sexual experience, primarily amongst a minority of the LGBTQ+ community. However, there are significant physical and mental health implications associated with it, which at present are inadequately addressed by services in an integrated manner. By attending this masterclass, delegates will develop an understanding of what Chemsex is and its complex association with healthcare, criminal justice and social care systems. There will be opportunity for discussion to consider how we can improve the identification, assessment and multi-agency support for this vulnerable, under-recognised and often-stigmatised group of individuals.
Chair: Dr Brad Hillier, Consultant Forensic Psychiatrist, West London NHS Trust, Chair, Health and Justice Liaison Group Project Sagamore
An introduction to Chemsex and its association with mental illness - Dr Elliott Carthy, Specialty Registrar in Forensic Psychiatry, Oxford Health NHS Foundation Trust
What are the current psychosocial treatments available? - Monty Moncrieff, Chief Executive London Friend, providing Antidote Service
The interface between sexual health, drug use and mental health - Dr Mark Pakianathan, Consultant Physician in Sexual Health and HIV, Guy’s and St Thomas’ NHS Foundation Trust
Dr Brad Hillier, Consultant Forensic Psychiatrist, West London NHS Trust, Chair, Health and Justice Liaison Group Project Sagamore
